# Marion Delcroix

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marion-delcroix/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,269 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 72 |
| i10-index | 200 |
| Last Known Institution | Rega Institute for Medical Research |
| OpenAlex ID | https://openalex.org/A5066741453 |
| ORCID iD | https://orcid.org/0000-0001-8394-9809 |
| Works | 587 |

## Researcher papers

- [2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension-the-task/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary/)
- [Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension](https://scholariq.org/papers/macitentan-and-morbidity-and-mortality-in-pulmonary-arterial-hypertension/)
- [Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry](https://scholariq.org/papers/elderly-patients-diagnosed-with-idiopathic-pulmonary-arterial-hypertension/)
- [ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension](https://scholariq.org/papers/ers-statement-on-exercise-training-and-rehabilitation-in-patients-with-severe/)
- [Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/switching-to-riociguat-versus-maintenance-therapy-with-phosphodiesterase-5/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes-2/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

## Researcher university

- [Rega Institute for Medical Research](https://scholariq.org/institutions/rega-institute-for-medical-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.